CAR-T/TCR and Cellular Therapeutics Support

Smithers Avanza Bioanalytical Services currently supports autologous and allogenic CAR-T and TCR programs at various stages of pre- and clinical development. Smithers Avanza bioanalytical services provides fit-for-purpose biomarker as well as CAR and TCR ADA services for both immune effectors and immune modulators.